CHU de Rennes, Hopital de Pontchaillou

Rennes 35033

3 studies enrolling now · 9 studies all time

What they study most

Crohn's Disease, Diffuse Large B-cell Lymphoma, Diffuse Large-cell B-cell Lymphoma, Extensive-stage Small-cell Lung Cancer, Lymphoma, Non-small Cell Lung Cancer, Pouchitis, Spasticity as Sequela of Stroke

Studies at this site

• A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma — Recruiting now
• Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer — Recruiting now
• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
• A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development — Running, not enrolling
• Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL) — Stopped early
• Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis — Completed
• A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis — Completed
• Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) — Completed
• Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease — Completed